AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34743231
Drug: Sham-placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-placebo treatment
Trial: 34127491
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with intravenous fluid coloading and phenylephrine infusion
Trial: 34219653
Drug: CYD-TDV dengue
RxNorm normalized name: dengue virus live antigen, CYD serotype 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD-TDV dengue vaccine
Trial: 33482893
Drug: Immediate SDB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate SDB treatment with ASV
Trial: 34635547
Drug: GABA 600
RxNorm normalized name: GABA
DrugBank: gamma-Aminobutyric acid (DB02530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GABA 600 mg
Trial: 36375329
Drug: Viloxazine extended-release
RxNorm normalized name: viloxazine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viloxazine extended-release (viloxazine ER, Qelbree®), flexible-dose (200-600 mg)
Trial: 32886746
Drug: 7-session modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-session modified Mindfulness-Based Cognitive Therapy (MBCT) for 10 weeks with telephone follow-up
Trial: 35935625
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg
Trial: 33094931
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg TDS for 8 weeks
Trial: 33094931
Drug: Calcium tablets
RxNorm normalized name: Leucovorin Calcium Tablets
DrugBank: Calcium sulfate (DB15533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium tablets as placebo (control)
Trial: 37007930
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept injection (IAI)
Trial: 35038990
Drug: Support for
RxNorm normalized name: GNP Diabetic Support Formula Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Support for traditional midwives with a monthly stipend and training from an intercultural broker in intervention communities.
Trial: 33211063
Drug: Pembrolizumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab (200 mg IV every 3 weeks) + Bevacizumab (15 mg/kg IV every 3 weeks) + Oral Cyclophosphamide (50 mg once daily)
Trial: 35926990
Drug: PA coaching
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PA coaching intervention underpinned by motivational interviewing and cognitive‐behavioural therapy
Trial: 34473215
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 mL IV normal saline 60 minutes before anesthesia)
Trial: 34473215
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg IV 60 minutes before anesthesia)
Trial: 34790521
Drug: 2-L PEG
RxNorm normalized name: Iron(2+) L-ascorbate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-L PEG
Trial: 36154349
Drug: Ibuprofen (IBG)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBG) 400 mg administered 15 min prior to the trial and after 5 h
Trial: 36072608
Drug: FF/UMEC/VI 100/62.5/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF/UMEC/VI 100/62.5/25 mcg
Trial: 36072608
Drug: BUD/FOR 400/12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD/FOR 400/12 mcg
Trial: 34348352
Drug: Pimecrolimus 1%
RxNorm normalized name: PIMECROLIMUS 1% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimecrolimus 1% cream (PIM)
Trial: 34250712
Drug: Combined IPL/fractional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined IPL/fractional Er:YAG treatment
Trial: 35775679
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment responders (Group MR)
Trial: 32754804
Drug: GAD-alum immunotherapy
RxNorm normalized name: alum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAD-alum immunotherapy (recombinant GAD65 conjugated to aluminium hydroxide)
Trial: 35879804
Drug: Immediate-release carvedilol-IR
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release carvedilol-IR
Trial: 34665453
Drug: Myo-inositol (MI)
RxNorm normalized name: myo-inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Myo-inositol (MI) 4 g/day
Trial: 34190055
Drug: Wnt16 gKO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wnt16 gKO mice with high dosage VitD diet
Trial: 35055558
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy group (PTG) (n = 19)
Trial: 35039498
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (placebo-controlled)
Trial: 34626918
Drug: Elemental diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental diet (ED) - Elental® 160 g/day
Trial: 33045216
Drug: Netarsudil 0.02%
RxNorm normalized name: NETARSUDIL 0.02% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netarsudil 0.02% ophthalmic solution
Trial: 32855054
Drug: Morphine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (40 mcg)
Trial: 33084081
Drug: Ketamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (20 mg)
Trial: 36081295
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 g/day)
Trial: 32464266
Drug: Daylight photodynamic
RxNorm normalized name: calcium carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daylight photodynamic therapy (DL‐PDT)
Trial: 34746999
Drug: Intravenous Vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Vitamin C (2 g every 6 hours for 5 days)
Trial: 33539744
Drug: Carboplatin-based doublet
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin-based doublet alone (standard chemotherapy)
Trial: 33985942
Drug: Tildrakizumab 200
RxNorm normalized name: Tildrakizumab
DrugBank: Tildrakizumab (DB14004)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tildrakizumab 200 mg every 4 weeks (Q4W)
Trial: 33985942
Drug: Tildrakizumab 20
RxNorm normalized name: Tildrakizumab
DrugBank: Tildrakizumab (DB14004)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tildrakizumab 20 mg Q12W (switched to 200 mg at W24)
Trial: 35451678
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg zinc gluconate daily)
Trial: 34563627
Drug: High-dose electro-acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose electro-acupuncture (EA) - seven times each chemotherapy cycle for three cycles
Trial: 34563627
Drug: Low-dose electro-acupuncture
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose electro-acupuncture (EA) - three times each chemotherapy cycle
Trial: 34563627
Drug: High-dose electro-acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose electro-acupuncture (EA)
Trial: 32950920
Drug: Large marker
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large marker (14 mm, 2 g)
Trial: 35875916
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine 2 μg/kg
Trial: 35875916
Drug: Oral melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral melatonin 0.5 mg kg ‐1
Trial: 33508735
Drug: Cognitive Orientation
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Orientation to daily Occupational Performance (CO-OP) with additional parental coaching
Trial: 35005205
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise training (60 min/session, twice/week for 24 weeks)
Trial: 33038262
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care plus 12-week intervention (weekly choir rehearsal and daily breathing exercises)
Trial: 35475684
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (LGG) 60 billion CFU daily for 4 weeks
Trial: 33794205
Drug: Avelumab plus
RxNorm normalized name: Avelumab
DrugBank: Avelumab (DB11945)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Avelumab plus chemoradiotherapy (10 mg/kg avelumab intravenously every 2 weeks plus 100 mg/m2 cisplatin every 3 weeks plus intensity‐modulated radiotherapy with standard fractionation of 70 Gy)
Trial: 35099133
Drug: Sublingual Nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual Nitroglycerin (NTG) administration
Trial: 33213378
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day tolvaptan
Trial: 33213378
Drug: 7.5 mg/day
RxNorm normalized name: nicotine 7.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/day tolvaptan
Trial: 39743172
Drug: Beta-blockers (BB)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (BB)
Trial: 35732345
Drug: Febuxostat or
RxNorm normalized name: febuxostat Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat or Allopurinol (discontinuation)
Trial: 33526287
Drug: Low SMI
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low SMI after neoadjuvant chemotherapy
Trial: 34312159
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg calcium propionate (PA)
Trial: 32895660
Drug: Selenium 200
RxNorm normalized name: SELENIUM 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium 200 mcg tablets twice daily
Trial: 34397746
Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
RxNorm normalized name: Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) once daily
Trial: 38501300
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis
Trial: 34689863
Drug: High-dose urokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose urokinase (50,000 IU injected daily, total 100,000 IU per day)
Trial: 34689863
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20,000 IU injected daily, total 40,000 IU per day)
Trial: 34689863
Drug: High-dose urokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose urokinase treatment
Trial: 32991046
Drug: D-phenylalanine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-phenylalanine (10 g)
Trial: 37301768
Drug: Standard antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antihypertensive treatment
Trial: 37938495
Drug: Erythropoiesis-stimulating agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoiesis-stimulating agents (ESA)
Trial: 33069881
Drug: Ornithine phenylacetate
RxNorm normalized name: phenylacetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornithine phenylacetate (OP) 10, 15, or 20 g/d
Trial: 35679098
Drug: Exenatide 2
RxNorm normalized name: exenatide 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 2 mg once weekly
Trial: 34214867
Drug: Cerebrolysin (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (intravenous as add-on therapy)
Trial: 35587322
Drug: Limited adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Limited adjuvant tamoxifen treatment
Trial: 34708706
Drug: Cervical lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cervical lidocaine spray only
Trial: 34708706
Drug: Cervical lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cervical lidocaine spray and naproxen tablet
Trial: 33377367
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg daily for 4 months)
Trial: 32152868
Drug: Brief Behavioral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Behavioral Therapy for Insomnia (BBT-I)
Trial: 35263436
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg/day for 120 days
Trial: 32367378
Drug: ZnO 30
RxNorm normalized name: ZNO 30 MG/ML Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnO 30 mg Zn/kg
Trial: 32367378
Drug: ZnO 60
RxNorm normalized name: ZNO 60 MG/ML Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnO 60 mg Zn/kg
Trial: 32367378
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (30.3 mg Zn/kg diet)
Trial: 33795116
Drug: Low-dose everolimus
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose everolimus and low-dose tacrolimus (RADTAC group)
Trial: 33795116
Drug: Standard-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose tacrolimus (TAC group)
Trial: 34098331
Drug: 10% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% lidocaine spray
Trial: 39007830
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation (OAC)
Trial: 34913767
Drug: Semi‐hepatic sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semi‐hepatic sequential radiotherapy (Group B)
Trial: 33944876
Drug: Standard infliximab
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard infliximab therapy
Trial: 36326260
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of sodium citrate and treprostinil in diluent with magnesium chloride (10 μL/h) with 15 unit-equivalent boluses (150 μL) at 3, 6, and 9 hours after initiation
Trial: 36326260
Drug: Arm infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arm infusion site
Trial: 36326260
Drug: Thigh infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thigh infusion site
Trial: 37568242
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam
Trial: 36048114
Drug: Low-nicotine dose
RxNorm normalized name: nicotine Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-nicotine dose (3% JUUL)/nonpreferred flavor
Trial: 36048114
Drug: High-nicotine dose
RxNorm normalized name: nicotine Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-nicotine dose (5% JUUL)/nonpreferred flavor
Trial: 36048114
Drug: High dose/preferred
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose/preferred flavor
Trial: 32207707
Drug: RPMF without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RPMF without local chondroprotective therapy
Trial: 35853131
Drug: Motivational interviews
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational interviews (MI) - 4 sessions at weekly intervals
Trial: 32719055
Drug: As-needed combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As-needed combination preventer and reliever therapy
Trial: 32719055
Drug: Maintenance budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Maintenance budesonide plus terbutaline reliever therapy
Trial: 34994269
Drug: Triple Pill
RxNorm normalized name: Triple Wormer Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple Pill (telmisartan 20 mg, amlodipine 2.5 mg, indapamide 1.25 mg)
Trial: 36165681
Drug: Intralesional HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional HBV vaccine
Trial: 36165681
Drug: Intramuscular HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular HBV vaccine
Trial: 32816255
Drug: Individual empowerment
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual empowerment and knowledge of treatment benefits
Trial: 34223253
Drug: Recombinant follicle-stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant follicle-stimulating hormone (FSH)
Trial: 38905580
Drug: Topical capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical capsaicin
Trial: 35910068
Drug: 0.2 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 μg/kg of sufentanil
Trial: 35582945
Drug: Client‐centred activities
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client‐centred activities of daily living (CADL) intervention
Trial: 32986904
Drug: Action Observation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Action Observation Therapy (AOT) - observation of uni/bimanual goal-directed actions followed by execution
Trial: 33545483
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of serum BPA (2.92 ng/mL)
Trial: 32068423
Drug: Cognitive AS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive AS treatment
Trial: 36109825
Drug: Dexamethasone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (6 mg once daily for 7 days)
Trial: 36246990
Drug: High-dose Dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Dexmedetomidine
Trial: 36246990
Drug: Medium-dose Dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose Dexmedetomidine
Trial: 36246990
Drug: Low-dose Dexmedetomidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Dexmedetomidine
Trial: 34755269
Drug: Colchicine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1.5 mg at baseline and 0.5 mg BID PO for 10 days)
Trial: 34052927
Drug: Active photobiomodulation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active photobiomodulation (PBM) treatment (pulsed near-infrared 808 nm Ga-Al-As laser, 250 mW, 8.8 J/cm2) for up to 12 weeks in addition to standard care
Trial: 34865002
Drug: Treatment arms
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment arms (not specified)
Trial: 32542370
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 ml saline)
Trial: 33601334
Drug: Weekly feedback
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly feedback
Trial: 32536056
Drug: Fuzheng Huayu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuzheng Huayu capsule
Trial: 33863614
Drug: Supervised formal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised formal physical therapy (PT)
Trial: 33396496
Drug: Creative Music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creative Music Therapy (CMT)
Trial: 32468719
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg fingolimod HCl capsule (Lebrina)
Trial: 32468719
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations of fingolimod
Trial: 35685899
Drug: basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: basic treatment + electroacupuncture
Trial: 34309987
Drug: Melissa officinalis
RxNorm normalized name: melissa officinalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melissa officinalis tea (MO tea), 2-g dried leaves/250 mL in hot water, two times/day for 12 weeks, in addition to lifestyle modification recommendations.
Trial: 33059801
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 drops (900 IU/d) for 25 days
Trial: 32189338
Drug: Pregabalin 14
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 14 mg/kg/d
Trial: 36233538
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (low-intensity exercise without TJ‐41 treatment) for 12 weeks
Trial: 37042545
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rizatriptan
Trial: 34706567
Drug: Physiologic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiologic saline solution
Trial: 34342012
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for 12 weeks